Literature DB >> 17032877

Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study.

S J Price1, R Jena, N G Burnet, P J Hutchinson, A F Dean, A Peña, J D Pickard, T A Carpenter, J H Gillard.   

Abstract

BACKGROUND AND
PURPOSE: The efficacy of radiation therapy, the mainstay of treatment for malignant gliomas, is limited by our inability to accurately determine tumor margins. As a result, despite recent advances, the prognosis remains appalling. Because gliomas preferentially infiltrate along white matter tracks, methods that show white matter disruption should improve this delineation. In this study, results of histologic examination from samples obtained from image-guided brain biopsies were correlated with diffusion tensor images.
METHODS: Twenty patients requiring image-guided biopsies for presumed gliomas were imaged preoperatively. Patients underwent image-guided biopsies with multiple biopsies taken along a single track that went into normal-appearing brain. Regions of interest were determined from the sites of the biopsies, and diffusion tensor imaging findings were compared with glioma histology.
RESULTS: Using diffusion tissue signatures, it was possible to differentiate gross tumor (reduction of the anisotropic component, q > 12% from contralateral region), from tumor infiltration (increase in the isotropic component, p > 10% from contralateral region). This technique has a sensitivity of 98% and specificity of 81%. T2-weighted abnormalities failed to identify the margin in half of all specimens.
CONCLUSION: Diffusion tensor imaging can better delineate the tumor margin in gliomas. Such techniques can improve the delineation of the radiation therapy target volume for gliomas and potentially can direct local therapies for tumor infiltration.

Entities:  

Mesh:

Year:  2006        PMID: 17032877      PMCID: PMC7977915     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

1.  Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures.

Authors:  C Studholme; D L Hill; D J Hawkes
Journal:  Med Phys       Date:  1997-01       Impact factor: 4.071

2.  Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.

Authors:  M M Fitzek; A F Thornton; J D Rabinov; M H Lev; F S Pardo; J E Munzenrider; P Okunieff; M Bussière; I Braun; F H Hochberg; E T Hedley-Whyte; N J Liebsch; G R Harsh
Journal:  J Neurosurg       Date:  1999-08       Impact factor: 5.115

3.  Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.

Authors:  D Croteau; L Scarpace; D Hearshen; J Gutierrez; J L Fisher; J P Rock; T Mikkelsen
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

4.  Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Fatih Ors; Cem Tayfun; Taner Uçöz
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

5.  Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.

Authors:  June L Chan; Susan W Lee; Benedick A Fraass; Daniel P Normolle; Harry S Greenberg; Larry R Junck; Stephen S Gebarski; Howard M Sandler
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

6.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

7.  Reliability of computed tomography in assessing histopathological features of malignant supratentorial gliomas.

Authors:  A Lilja; K Bergström; B Spännare; Y Olsson
Journal:  J Comput Assist Tomogr       Date:  1981-10       Impact factor: 1.826

8.  Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma.

Authors:  R Jena; S J Price; C Baker; S J Jefferies; J D Pickard; J H Gillard; N G Burnet
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-12       Impact factor: 4.126

9.  Detecting glioma invasion of the corpus callosum using diffusion tensor imaging.

Authors:  S J Price; A Peña; N G Burnet; J D Pickard; J H Gillard
Journal:  Br J Neurosurg       Date:  2004-08       Impact factor: 1.596

10.  Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas.

Authors:  Stephen J Price; Alonso Peña; Neil G Burnet; Raj Jena; Hadrian A L Green; T Adrian Carpenter; John D Pickard; Jonathan H Gillard
Journal:  Eur Radiol       Date:  2004-06-25       Impact factor: 5.315

View more
  93 in total

Review 1.  Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist's perspective.

Authors:  A Shenoy
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Clinical target volume delineation in glioblastomas: pre-operative versus post-operative/pre-radiotherapy MRI.

Authors:  P Farace; M G Giri; G Meliadò; D Amelio; L Widesott; G K Ricciardi; S Dall'Oglio; A Rizzotti; A Sbarbati; A Beltramello; S Maluta; M Amichetti
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

Review 3.  Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.

Authors:  James R Fink; Mark Muzi; Melinda Peck; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

4.  Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps.

Authors:  Antonella Castellano; Marina Donativi; Roberta Rudà; Giorgio De Nunzio; Marco Riva; Antonella Iadanza; Luca Bertero; Matteo Rucco; Lorenzo Bello; Riccardo Soffietti; Andrea Falini
Journal:  Eur Radiol       Date:  2015-08-30       Impact factor: 5.315

5.  Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.

Authors:  Anirudh Sattiraju; Xiaobing Xiong; Darpan N Pandya; Thaddeus J Wadas; Ang Xuan; Yao Sun; Youngkyoo Jung; Kiran Kumar Solingapuram Sai; Jay F Dorsey; King C Li; Akiva Mintz
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

6.  Novel Surgical Approaches to High-Grade Gliomas.

Authors:  Fahid Tariq Rasul; Colin Watts
Journal:  Curr Treat Options Neurol       Date:  2015-09       Impact factor: 3.598

Review 7.  Clinical Imaging for Diagnostic Challenges in the Management of Gliomas: A Review.

Authors:  Alipi V Bonm; Reed Ritterbusch; Patrick Throckmorton; Jerome J Graber
Journal:  J Neuroimaging       Date:  2020-01-10       Impact factor: 2.486

8.  Intraoperative DTI and brain mapping for surgery of neoplasm of the motor cortex and the corticospinal tract: our protocol and series in BrainSUITE.

Authors:  Giancarlo D'Andrea; Albina Angelini; Andrea Romano; Antonio Di Lauro; Giovanni Sessa; Alessandro Bozzao; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2012-02-28       Impact factor: 3.042

9.  Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.

Authors:  Michael Lundemann; Per Munck Af Rosenschöld; Aida Muhic; Vibeke A Larsen; Hans S Poulsen; Svend-Aage Engelholm; Flemming L Andersen; Andreas Kjær; Henrik B W Larsson; Ian Law; Adam E Hansen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-02       Impact factor: 9.236

10.  Diffusion tensor tractography in the presurgical assessment of cerebral gliomas.

Authors:  Zahra Farshidfar; Fariborz Faeghi; Mostafa Mohseni; Afsoun Seddighi; Homayoun Hadizadeh Kharrazi; Jamil Abdolmohammadi
Journal:  Neuroradiol J       Date:  2014-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.